{"gene":"TCF3","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":1994,"finding":"E2A (TCF3) gene products (E12 and E47) are required for B cell formation; E2A-null mice completely lack mature B cells with a developmental block prior to immunoglobulin DJ rearrangement, demonstrating that E2A is a central regulator of early B cell differentiation.","method":"Gene targeting/knockout in mice, flow cytometry, PCR for Ig rearrangements","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent knockout studies replicated in the same year with clear developmental phenotype and molecular markers","pmids":["8001125","8001124"],"is_preprint":false},{"year":1997,"finding":"E2A transcriptionally activates the cyclin-dependent kinase inhibitor p21CIP1/WAF1 promoter through E-box elements (E1–E3) near the transcription start site, providing a mechanism for E2A-mediated growth suppression; Id1 overexpression inhibits p21 expression and accelerates cell growth.","method":"Luciferase reporter/cotransfection assays, promoter deletion/mutational analysis, endogenous p21 mRNA/protein quantification in 293T cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (reporter assay, mutagenesis, endogenous gene analysis) in a single study","pmids":["9315646"],"is_preprint":false},{"year":1993,"finding":"E2A proteins (E12 and E47) are subunits of B-cell-specific E2-box DNA-binding complexes; both E2A and E2-2 polypeptides are present in immunoglobulin enhancer-binding complexes in pre-B cells, whereas mature B cells contain only E2A products.","method":"Monoclonal antibody immunoprecipitation, mobility shift assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal immunoprecipitation with specific antibodies, independently corroborated by multiple labs","pmids":["8497267"],"is_preprint":false},{"year":2003,"finding":"Notch signaling induces degradation of E2A proteins (E12 and E47) via MAP kinase (p42/p44)-dependent phosphorylation of E47, which enhances association with the SCF(Skp2) E3 ubiquitin ligase, leading to ubiquitination and proteasome-mediated degradation; this pathway is active in B and T cells.","method":"Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor treatment, siRNA knockdown, dominant-negative and activated kinase expression","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biochemical methods (co-IP, ubiquitination assay, kinase inhibitor, siRNA) in a single study","pmids":["14592976"],"is_preprint":false},{"year":2004,"finding":"CHIP (carboxyl terminus of Hsc70-interacting protein) binds E47 through the E protein homology domains EHD2 and EHD3 and, together with Hsc70, forms a pre-ubiquitination complex with E47 and Skp2, facilitating E47 ubiquitination and proteasome-mediated degradation in a phosphorylation-dependent manner.","method":"Yeast two-hybrid screen, co-immunoprecipitation, siRNA knockdown, ubiquitination assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (yeast two-hybrid, co-IP, siRNA, ubiquitination assay) in a single focused study","pmids":["15456869"],"is_preprint":false},{"year":1997,"finding":"E2A proteins (E12/E47) are degraded via the ubiquitin-proteasome pathway; UbcE2A (a ubiquitin-conjugating enzyme) interacts specifically with a 54-amino acid region of E47 distinct from the HLH domain, and antisense UbcE2A reduces E12 degradation.","method":"Yeast two-hybrid, co-immunoprecipitation, proteasome inhibitor (MG132), in vivo ubiquitination, antisense RNA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (yeast two-hybrid, proteasome inhibitor, in vivo ubiquitination, antisense rescue) in a single study","pmids":["9013644"],"is_preprint":false},{"year":2002,"finding":"E2A co-elutes with histone acetyltransferases p300, CBP, and PCAF in pre-B cell nuclear extracts; these HATs acetylate E2A in vitro, enhance E2A-mediated transcription, and promote nuclear retention of E2A; genetic interaction between E2A and p300 heterozygosity impairs B cell development.","method":"Gel filtration, co-immunoprecipitation, in vitro acetylation assay, transcription reporter assay, p300 catalytic mutant, compound heterozygous mouse crosses","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro acetylation assay plus co-IP plus genetic epistasis and catalytic mutant, single lab","pmids":["12435739"],"is_preprint":false},{"year":2001,"finding":"Tcf3 acts independently of its β-catenin-interacting domain to suppress epidermal terminal differentiation and promote outer root sheath/bulge stem cell identity in skin; these functions are dependent on Tcf3's DNA-binding and Groucho repressor-binding domains.","method":"Transgenic mouse overexpression with domain deletion constructs, keratinocyte differentiation markers","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — domain dissection in transgenic mice with multiple differentiation readouts, single lab","pmids":["11445543"],"is_preprint":false},{"year":2006,"finding":"Tcf3 governs stem cell features in skin; forced reactivation of Tcf3 in committed epidermal cells induces genes associated with an undifferentiated, Wnt-inhibited state and represses transcriptional regulators of all three skin differentiation lineages (epidermal, sebaceous, hair follicle).","method":"Inducible transgenic mouse system, gene expression profiling","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — inducible gain-of-function in vivo with multiple differentiation lineage readouts","pmids":["17018284"],"is_preprint":false},{"year":2010,"finding":"Wnt signaling stimulates TCF3 phosphorylation by recruiting HIPK2 (homeodomain-interacting protein kinase 2) to TCF3 via β-catenin; this phosphorylation causes TCF3 dissociation from target gene promoters, derepressing Wnt target genes during anteroposterior axis specification in Xenopus.","method":"Xenopus embryo and mammalian cell phosphorylation assays, chromatin immunoprecipitation, phosphorylation-resistant TCF3 mutants, developmental gene expression readouts","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — biochemical phosphorylation assay, ChIP, structure-function with point mutants, functional developmental rescue","pmids":["20951344"],"is_preprint":false},{"year":2001,"finding":"Tcf3 can inhibit β-catenin turnover by competing with axin and APC for β-catenin binding; Tcf3 is phosphorylated by both GSK3 and CK1ε, with CK1ε phosphorylation stimulating Tcf3–β-catenin binding (reversed by GSK3), and Tcf3 synergizes with CK1ε to stabilize β-catenin.","method":"Xenopus embryo and extract biochemistry, β-catenin degradation assays, dominant-negative constructs, peptide competition","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in Xenopus extracts with multiple competing biochemical methods, single lab","pmids":["11524435"],"is_preprint":false},{"year":2011,"finding":"Tcf3 functions as a transcriptional repressor in ESCs; genetic ablation of Tcf3 replaces the requirement for exogenous Wnt3a or GSK3 inhibition for ESC self-renewal, demonstrating that relief of Tcf3-mediated repression (not Tcf3–β-catenin transcriptional activation) is the necessary downstream effect of Wnt signaling; Tcf3 and Tcf1 together recruit Wnt-stabilized β-catenin to Oct4 binding sites.","method":"Genetic knockout, gene expression analysis, ChIP, Wnt3a treatment, GSK3 inhibitor treatment","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic ablation with multiple epistasis readouts, ChIP, single lab","pmids":["21685894"],"is_preprint":false},{"year":2012,"finding":"Tcf3–β-catenin interaction is not required for gastrulation but is required for post-gastrulation development (limb, vascular, neural tube, eyelid); Tcf3 directly represses Lef1 transcription, and Wnt/β-catenin counteracts this repression, allowing Lef1–β-catenin complexes to activate target genes (indirect activation mechanism).","method":"Tcf3ΔN knock-in mouse (ablates β-catenin interaction), genetic analysis, gene expression","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — precise domain knock-in in vivo with developmental and molecular phenotype characterization","pmids":["22573616"],"is_preprint":false},{"year":1999,"finding":"EBF and E2A synergistically activate transcription of B-cell-specific genes including Pax5, Rag1, Rag2, and mb-1; Ebf+/−E2a+/− compound heterozygous mice show a marked pro-B cell defect greater than either single heterozygote, demonstrating genetic collaboration in B lymphopoiesis.","method":"Compound heterozygous mouse genetics, gene expression analysis, transfection synergy assay","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with compound heterozygotes and cellular transcription assays","pmids":["10435576"],"is_preprint":false},{"year":2004,"finding":"E2A is required for the complete cell-cycle arrest observed at the pre-TCR checkpoint; E2A-deficient thymocytes exhibit abnormal cell-cycle progression prior to pre-TCR expression, and E47 can act in concert with Bcl-2 to induce cell-cycle arrest in vitro.","method":"E2A conditional knockout, cell-cycle analysis, double-mutant epistasis (LAT, Lck, Fyn), in vitro cell-cycle arrest assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in vivo plus in vitro functional assay, single lab","pmids":["14685278"],"is_preprint":false},{"year":2002,"finding":"E2A directly activates chromatin modification and germ-line transcription at the immunoglobulin kappa locus in pre-B cells; E2A binds the κEi and κE3' enhancers, and induction of E47 in E2A-deficient pre-B cells rescues Igκ germ-line transcription, Jκ accessibility, and V(D)J recombination; IRF-4 is required for E2A recruitment to κE3'.","method":"E2A-deficient pre-B cells, inducible E47 reconstitution, chromatin immunoprecipitation, recombination assay, IRF-4 knockdown","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reconstitution in knockout cells with ChIP and functional recombination readout","pmids":["16428437"],"is_preprint":false},{"year":2004,"finding":"E2A promotes survival of pre-B and mature B lymphocytes; conditional deletion of E2A in mature B cells causes rapid depletion within 24 h, and E2A/HEB double-deficient pre-B lines show dramatically enhanced apoptosis upon growth arrest.","method":"IFN-inducible Cre conditional knockout, adoptive transfer, apoptosis assay in double-deficient cell lines","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional knockout with in vivo and in vitro apoptosis readouts; survival function not fully mechanistically resolved","pmids":["15078898"],"is_preprint":false},{"year":2006,"finding":"E2A expression stimulates immunoglobulin hypermutation in chicken DT40 B cells; E2A inactivation strongly reduces Ig L chain mutation rate without affecting AID expression, and re-expression of E12 or E47 complements the defect, suggesting E2A recruits AID to Ig loci.","method":"E2A gene inactivation in DT40 cells, Ig hypermutation frequency assay, cDNA complementation","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean loss-of-function with functional readout in a single chicken B cell model; AID recruitment is inferred, not directly shown","pmids":["16785535"],"is_preprint":false},{"year":2011,"finding":"E2A binds enhancer elements across the FOXO1 locus to directly activate Foxo1 expression in common lymphoid progenitors; E2A and HEB jointly induce FOXO1 at the earliest stage of B-cell specification.","method":"ChIP (E2A binding to FOXO1 locus), gene expression in E2A- and HEB-deficient CLPs, compound knockout mice","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct binding plus genetic loss-of-function in vivo with compound knockouts","pmids":["21972416"],"is_preprint":false},{"year":2020,"finding":"E2A directly activates expression of Rag genes in T and B cells through distinct sets of cis-regulatory elements (R-TEn in T cells; R1B/R2B in B cells); E2A binding to the E-box in R-TEn is essential for chromatin remodeling and Rag expression in T cells.","method":"Transgenic mice with enhancer deletions, E2A binding-site point mutation knock-in mice, chromatin conformation analysis, gene expression","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple mouse strains with enhancer and binding-site mutations, chromatin accessibility readout, single lab","pmids":["32887843"],"is_preprint":false},{"year":2001,"finding":"E2A and HEB bind consecutive E-box elements in the pre-TCRα (pTα) promoter and directly activate pTα transcription; the specific E2A/HEB-DNA complex is observed exclusively in immature thymocytes and not in mature T cells.","method":"Promoter deletion analysis, EMSA, E2A/HEB overexpression, reporter assay in thymocytes","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA, reporter assay, overexpression; single lab","pmids":["11490000"],"is_preprint":false},{"year":2018,"finding":"Alternative splicing of TCF3 (E2A) controlled by hnRNP H/F produces E12 and E47 isoforms; high hnRNP H/F in hESCs promotes E12, while decreased hnRNP H/F during differentiation switches to E47; E47 represses E-cadherin expression, whereas E12 does not, linking TCF3 splicing to maintenance of hESC pluripotency.","method":"siRNA knockdown of hnRNP H/F, isoform-specific expression analysis, E-cadherin reporter/expression assay, hESC differentiation","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional splicing switch with isoform-specific gain-of-function readout plus knockdown phenotype, single lab","pmids":["30115631"],"is_preprint":false},{"year":2013,"finding":"TCF3/E2A drives p21 (CDKN1A) expression while repressing PUMA (BBC3) across cancer cell types; TCF3/E2A depletion impairs cell-cycle arrest and promotes apoptosis upon p53 activation, placing TCF3/E2A as a pathway-specific coregulator of p53 target gene selectivity.","method":"Genome-wide genetic screen (siRNA), gene expression analysis, cell-cycle and apoptosis assays in multiple cancer cell lines","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-scale screen validated by knockdown/phenotype assays; single lab","pmids":["23684607"],"is_preprint":false},{"year":2014,"finding":"Tcf3 promotes keratinocyte migration and skin wound healing non-cell-autonomously through upregulation of the secreted factor lipocalin-2; Stat3 acts as an upstream activator of Tcf3 in this wound-repair context, and Tcf3's promigration effects are independent of β-catenin binding.","method":"Tcf3 overexpression, wound healing assay, conditioned medium experiments, lipocalin-2 neutralization, Stat3 epistasis","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal assays including conditioned medium rescue; single lab","pmids":["24909826"],"is_preprint":false},{"year":2011,"finding":"Tcf3 functions as a repressor of epigenome state in ES cells; Tcf3 deletion increases AcH3 and decreases H3K9me3 genome-wide, and Tcf3-null ES cells reprogram somatic neural precursor cells more efficiently upon cell fusion.","method":"Tcf3 knockout ES cells, chromatin immunoprecipitation for AcH3/H3K9me3, cell fusion reprogramming efficiency assay","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for histone marks in knockout cells linked to functional reprogramming readout; single lab","pmids":["21730189"],"is_preprint":false},{"year":2011,"finding":"Tcf3 directly represses cdx4 expression through binding multiple sites in the cdx4 regulatory region, requiring Groucho/TLE and HDAC1 as corepressors; the transcription factor E4f1 derepresses cdx4 by dissociating corepressors from Tcf3 (without displacing Tcf3 from DNA), and the E3 ligase Lnx2b counteracts E4f1 as a scaffold.","method":"ChIP, reporter assays, co-IP, dominant-negative and overexpression in zebrafish embryos and mammalian cells","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus co-IP plus in vivo functional assays; single lab, zebrafish model","pmids":["21666599"],"is_preprint":false},{"year":1996,"finding":"LYL1 forms heterodimeric complexes with E2A proteins (E12 and E47) via HLH motif interactions; endogenous LYL1–E2A complexes exist in hematolymphoid cells and bind a preferred DNA sequence (5'-AACAGATG(T/g)T-3') distinct from the muE2 site.","method":"Yeast two-hybrid, in vitro HLH interaction, immunoprecipitation, PCR-assisted site selection, EMSA","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid confirmed by co-IP and DNA binding characterization; single lab","pmids":["8628307"],"is_preprint":false},{"year":2000,"finding":"E2A basic region residues establish DNA sequence specificity for particular CAN NTG E-box sites through the conformation of the basic region–DNA interaction; the E2A basic region can be directed toward different half-sites depending on its heterodimerization partner (e.g., MyoD or Twist).","method":"In vitro DNA binding assays with basic region mutants, site selection, heterodimer formation","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — systematic mutagenesis plus in vitro DNA binding; single lab, no in vivo validation","pmids":["10594029"],"is_preprint":false},{"year":2013,"finding":"E2A transcription factors limit expression of Gata3 in DN2 thymocytes to enable T-lymphocyte commitment; genetic or siRNA-mediated reduction of Gata3 rescues T-cell differentiation in E2A-deficient DN2 cells, placing E2A upstream of Gata3 in the T-cell commitment pathway.","method":"E2A conditional knockout, siRNA of Gata3, flow cytometry, differentiation assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis confirmed by siRNA rescue with clear cellular phenotype readout","pmids":["23297135"],"is_preprint":false},{"year":2007,"finding":"Simultaneous conditional deletion of E2A and HEB in developing thymocytes causes a severe developmental block before pre-TCR expression and dramatic reduction of Pre-Tα expression, with increased IL-7-driven proliferation; E2A and HEB together enforce cell-cycle arrest prior to pre-TCR expression.","method":"Double conditional knockout mice (Cre-mediated), cell-cycle analysis, IL-7 stimulation, pre-Tα expression analysis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — double conditional knockout with multiple functional and molecular readouts","pmids":["17442955"],"is_preprint":false},{"year":2021,"finding":"EZH2 epigenetically represses TCF3 expression (via H3K27 trimethylation), and DNMT3B independently methylates the TCF3 promoter to silence TCF3; TCF3 in turn directly activates CDKN1A (p21) transcription, establishing an EZH2/DNMT3B→TCF3→p21 axis in endometrial cancer.","method":"ChIP for H3K27me3, bisulfite sequencing of TCF3 promoter, TCF3 reporter assay, pharmacological inhibitors (GSK126, 5-Aza) in CDX and PDX models","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, DNA methylation mapping, functional rescue; single lab","pmids":["34175897"],"is_preprint":false},{"year":2024,"finding":"Id2 disrupts assembly of a Tcf3–LSD1 complex (via its HLH domain binding Tcf3), thereby preventing LSD1-mediated removal of H3K4me2 from Tcf3-occupied E-boxes in the Slamf6 promoter; this epigenetic mechanism regulates the generation of Slamf6+ progenitor exhausted CD8+ T cells.","method":"Co-immunoprecipitation, ChIP for H3K4me2, Id2 knockout, LSD1 inhibitor rescue, Id2 HLH domain mutant","journal":"Cellular & molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, ChIP, domain mutant, pharmacological rescue; single lab","pmids":["38287103"],"is_preprint":false},{"year":2021,"finding":"E2A directly regulates chromatin accessibility at enhancers of memory-related genes in CD8+ T cells; E2A overexpression increases the frequency of memory precursor effector cells and accelerates memory cell formation while decreasing short-lived effectors.","method":"Single-cell transcriptomics, gene regulatory network analysis, ATAC-seq, E2A ChIP/overexpression","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ATAC-seq + ChIP + overexpression phenotype; single lab","pmids":["33859041"],"is_preprint":false},{"year":2014,"finding":"E2A functions as a transcriptional activator predominantly by inducing open chromatin at target genes in pro-B, small pre-B, and immature B cells; acute protein degradation (dTAG) in vivo identifies E2A as required for Rag1, Rag2, Dntt, Irf4, and Irf8 activation as direct target genes.","method":"Auxin-inducible/dTAG acute protein degradation in mice, ChIP-seq, ATAC-seq, RNA-seq","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — acute in vivo protein degradation with chromatin accessibility and transcriptome profiling; rigorous design","pmids":["39179932"],"is_preprint":false},{"year":2022,"finding":"SHMT2 inhibition reduces intracellular glycine/formate, inhibits mTOR, and triggers autophagic degradation of TCF3 in Burkitt lymphoma cells; loss of TCF3 collapses tonic BCR signaling, which TCF3 controls and which is essential for BL cell survival.","method":"CRISPR-Cas9 screen, SHMT2 knockdown, pharmacological inhibition, mTOR pathway analysis, TCF3 protein level measurement","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR screen validated by mechanistic follow-up; mTOR–autophagy–TCF3 axis established in single lab","pmids":["34624079"],"is_preprint":false},{"year":2015,"finding":"TCF3 binds the MYC 3' Wnt-responsive element (WRE) to repress MYC in colorectal cancer cells; Wnt/β-catenin activation (via GSK3β inhibition) causes exchange of TCF3 for TCF4/β-catenin complexes at this element, activating MYC expression as quiescent cells re-enter the cell cycle.","method":"ChIP, shRNA knockdown of TCF3, TCF4, reporter assays, GSK3β inhibitor treatment, cell-cycle analysis","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct binding plus functional knockdown with MYC expression and cell-cycle readout; single lab","pmids":["25659031"],"is_preprint":false},{"year":2013,"finding":"TCF3 is constitutively associated with the Lhcgr promoter in granulosa cells, and dominant-negative TCF abolishes FSH-induced Lhcgr mRNA expression; PKA-phosphorylated β-catenin (Ser552/675) and SF1 occupy the Lhcgr promoter upon FSH treatment.","method":"Chromatin immunoprecipitation, dominant-negative TCF adenovirus, Lhcgr-luciferase reporter assay, microarray","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP showing direct promoter occupancy plus reporter and dominant-negative functional assays; single lab","pmids":["23754802"],"is_preprint":false},{"year":2011,"finding":"E2A directly interacts with CD38 regulatory E-box sequences in CLL cells (demonstrated by ChIP); E2A silencing reduces surface CD38 levels, and E2A binding is stronger at the G allele of the CD38 C→G polymorphism, linking E2A genotype-dependently to CD38 transcription.","method":"ChIP, siRNA knockdown, flow cytometry for CD38 surface expression","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus siRNA knockdown with functional readout; single lab","pmids":["21212793"],"is_preprint":false},{"year":2024,"finding":"TCF3 and TCF12 are key regulators of folliculogenesis; motif analysis and loss-of-function studies in oocytes show that TCF3 deficiency impairs activation of key oocyte genes and folliculogenesis, identified through H3K27ac mapping of putative enhancers.","method":"H3K27ac ChIP-seq in oocytes, TCF3 knockout, gene expression analysis","journal":"Nature cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enhancer mapping combined with knockout phenotype; single lab","pmids":["38839978"],"is_preprint":false},{"year":2014,"finding":"Tcf3-expressing cells in the hair follicle bulge are self-renewing multipotent stem cells in adult skin, as demonstrated by lineage tracing; Tcf3-expressing cells also mark persistent stem cells, transient progenitors, and actively differentiating cells in other stratified epithelia (paw skin, tongue, esophagus).","method":"Tcf3-CreER knock-in mouse, lineage tracing","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — lineage tracing with clean knock-in model; single lab, descriptive at the cellular level","pmids":["25038042"],"is_preprint":false}],"current_model":"TCF3 (E2A) is a broadly expressed basic helix-loop-helix transcription factor that forms homodimers and heterodimers to bind E-box elements; it functions as a master regulator of B and T lymphocyte development by directly activating lineage-specific genes (Foxo1, Rag1/2, Igκ locus, pTα, mb-1) and enforcing cell-cycle arrest checkpoints, while its activity is regulated post-translationally by ubiquitin-proteasome degradation (via UbcE2A/SCF(Skp2)/CHIP–Hsc70 complexes, triggered by MAP kinase phosphorylation downstream of Notch), by HAT-mediated acetylation (p300/CBP/PCAF) that promotes nuclear retention and transcriptional activation, and by alternative splicing (E12 vs. E47 isoforms controlled by hnRNP H/F) with distinct functional outputs; in stem cells and development TCF3 operates primarily as a transcriptional repressor (dependent on its DNA-binding and Groucho/TLE–HDAC1 corepressor-binding domains) that maintains an undifferentiated state, and is derepressed by Wnt/β-catenin signaling through HIPK2-mediated phosphorylation that dissociates TCF3 from target promoters, or by β-catenin competition that stabilizes β-catenin while TCF3 is later replaced by activating Tcf/Lef–β-catenin complexes at Wnt target loci."},"narrative":{"mechanistic_narrative":"TCF3 (E2A) is a basic helix-loop-helix transcription factor that binds E-box elements as homodimers or as heterodimers with partner bHLH proteins, and it operates as a context-dependent master regulator that acts as a transcriptional activator in lymphocyte development and as a repressor in stem cells and Wnt-responsive tissues [PMID:8001125, PMID:8001124, PMID:21685894, PMID:10594029]. In B and T lineages, E2A directly opens chromatin and activates a lineage-specific gene program — Foxo1, Rag1/Rag2, Dntt, Irf4/Irf8, the immunoglobulin kappa locus, and the pre-TCRalpha promoter — frequently in collaboration with the bHLH proteins HEB and EBF [PMID:10435576, PMID:16428437, PMID:21972416, PMID:11490000, PMID:39179932], and its loss arrests B cell development before Ig DJ rearrangement [PMID:8001125, PMID:8001124]. Beyond gene activation, E2A enforces cell-cycle control by transactivating the CDK inhibitor p21/CDKN1A through promoter E-boxes and by imposing the cell-cycle arrest checkpoint that precedes pre-TCR expression, while also promoting lymphocyte survival and T-lineage commitment by restraining Gata3 [PMID:9315646, PMID:14685278, PMID:23297135, PMID:17442955]. E2A activity is gated post-translationally: Notch-driven MAP-kinase phosphorylation routes E47 to SCF(Skp2)/CHIP-Hsc70-dependent ubiquitination and proteasomal degradation, p300/CBP/PCAF acetylation promotes nuclear retention and transcriptional activation, and hnRNP H/F-controlled alternative splicing partitions output between the E12 and E47 isoforms [PMID:14592976, PMID:15456869, PMID:12435739, PMID:30115631]. In stem cells and embryonic patterning, TCF3 functions as a Groucho/TLE- and HDAC1-dependent repressor that maintains an undifferentiated state and represses Wnt targets; relief of this repression — by HIPK2-mediated phosphorylation that dissociates TCF3 from promoters, by corepressor displacement, or by replacement with activating TCF/LEF-beta-catenin complexes — is the operative output of Wnt signaling [PMID:11445543, PMID:17018284, PMID:20951344, PMID:21685894, PMID:22573616, PMID:21666599]. TCF3 additionally tunes p53 target-gene selectivity and tonic B-cell-receptor signaling, linking it to cancer cell-cycle arrest, apoptosis, and lymphoma survival [PMID:23684607, PMID:34624079].","teleology":[{"year":1994,"claim":"Established that E2A is a non-redundant master regulator of early B lymphopoiesis rather than one of many redundant bHLH factors, by showing its loss blocks B cell development before Ig rearrangement.","evidence":"Gene knockout in mice with flow cytometry and PCR of Ig rearrangements","pmids":["8001125","8001124"],"confidence":"High","gaps":["Did not resolve which direct target genes mediate the block","Did not address T-lineage or non-hematopoietic roles"]},{"year":1996,"claim":"Defined how E2A achieves DNA-binding specificity by showing it heterodimerizes with partner bHLH proteins (LYL1) to bind distinct preferred E-box sequences, explaining combinatorial target selection.","evidence":"Yeast two-hybrid, co-IP, PCR site selection, EMSA in hematolymphoid cells","pmids":["8628307"],"confidence":"Medium","gaps":["In vivo functional consequence of LYL1-E2A complexes not established","Genome-wide occupancy of these complexes unknown"]},{"year":2000,"claim":"Showed at the structural level that the E2A basic region adopts partner-dependent conformations directing it to different E-box half-sites, providing a mechanism for combinatorial specificity.","evidence":"In vitro DNA binding with basic-region mutants and heterodimers (MyoD, Twist)","pmids":["10594029"],"confidence":"Medium","gaps":["No in vivo validation","No crystal/structural model of the complex"]},{"year":1997,"claim":"Connected E2A to growth suppression by identifying p21/CDKN1A as a direct E-box target and showing Id1 antagonizes this, framing E2A as a cell-cycle brake.","evidence":"Luciferase reporters, promoter mutagenesis, endogenous p21 measurement in 293T cells","pmids":["9315646"],"confidence":"High","gaps":["Done in 293T, not lymphocytes","Did not address other cell-cycle targets"]},{"year":1997,"claim":"Opened the post-translational regulation axis by demonstrating E2A is degraded via the ubiquitin-proteasome pathway through UbcE2A binding a discrete region of E47.","evidence":"Yeast two-hybrid, MG132 treatment, in vivo ubiquitination, antisense rescue","pmids":["9013644"],"confidence":"High","gaps":["E3 ligase identity not established here","Signal triggering degradation unknown at this point"]},{"year":2002,"claim":"Identified acetylation as an activating modification, showing p300/CBP/PCAF acetylate E2A to enhance transcription and nuclear retention, with genetic confirmation in B cell development.","evidence":"Gel filtration, co-IP, in vitro acetylation, reporter assay, p300 catalytic mutant, compound heterozygous mice","pmids":["12435739"],"confidence":"High","gaps":["Specific acetylated residues and their individual contributions not fully mapped","Interplay with degradation not resolved"]},{"year":2003,"claim":"Defined the upstream signal for E2A degradation, showing Notch-driven MAPK phosphorylation of E47 enhances SCF(Skp2) recruitment for ubiquitination, linking lineage signaling to E2A turnover.","evidence":"Co-IP, ubiquitination assay, proteasome inhibitor, siRNA, dominant-negative/active kinase in B and T cells","pmids":["14592976"],"confidence":"High","gaps":["Phosphosite mapping incomplete","Quantitative contribution to lineage decisions in vivo not resolved"]},{"year":2004,"claim":"Completed the degradation machinery model by showing CHIP and Hsc70 form a phosphorylation-dependent pre-ubiquitination complex with E47 and Skp2 via the EHD2/EHD3 domains.","evidence":"Yeast two-hybrid, co-IP, siRNA, ubiquitination assay","pmids":["15456869"],"confidence":"High","gaps":["Stoichiometry and ordering of complex assembly not determined","In vivo relevance to development not tested"]},{"year":1999,"claim":"Demonstrated E2A acts combinatorially with EBF to activate the B-lineage program (Pax5, Rag1/2, mb-1), establishing genetic collaboration rather than solo action.","evidence":"Compound heterozygous mouse genetics, expression analysis, transfection synergy","pmids":["10435576"],"confidence":"High","gaps":["Direct co-binding at shared enhancers not shown here","Hierarchy between E2A and EBF unresolved"]},{"year":2001,"claim":"Extended E2A's direct activation program to T lymphopoiesis by showing E2A/HEB bind and activate the pTalpha promoter selectively in immature thymocytes.","evidence":"Promoter deletion, EMSA, overexpression, reporter assay in thymocytes","pmids":["11490000"],"confidence":"Medium","gaps":["Reliance on reporter/overexpression rather than endogenous locus","Single lab"]},{"year":2001,"claim":"Revealed TCF3's separable Wnt-related biochemistry, showing it competes with axin/APC to stabilize beta-catenin and is phosphoregulated by CK1epsilon and GSK3.","evidence":"Xenopus extract biochemistry, beta-catenin degradation assays, peptide competition","pmids":["11524435"],"confidence":"High","gaps":["Relationship to TCF3's transcriptional repressor role not unified here","Mammalian in vivo relevance untested"]},{"year":2001,"claim":"Established TCF3 as a beta-catenin-independent repressor maintaining skin stem cell identity, dependent on its DNA-binding and Groucho repressor domains.","evidence":"Transgenic domain-deletion overexpression in mouse skin, differentiation markers","pmids":["11445543"],"confidence":"High","gaps":["Direct repressed target genes not enumerated","Mechanism of Groucho recruitment in skin not detailed"]},{"year":2002,"claim":"Showed E2A directly drives chromatin opening and germline transcription at the Igk locus, with IRF-4 required for recruitment, mechanistically linking E2A to V(D)J accessibility.","evidence":"Inducible E47 reconstitution in E2A-null pre-B cells, ChIP, recombination assay, IRF-4 knockdown","pmids":["16428437"],"confidence":"High","gaps":["Chromatin-remodeling cofactors recruited by E2A not identified","Generality to other Ig loci not tested here"]},{"year":2004,"claim":"Defined E2A's checkpoint and survival functions, showing it enforces cell-cycle arrest at the pre-TCR checkpoint and supports B-lymphocyte survival.","evidence":"Conditional knockouts, cell-cycle analysis, epistasis, apoptosis assays","pmids":["14685278","15078898"],"confidence":"High","gaps":["Survival function not fully mechanistically resolved (idx 16 Medium)","Direct anti-apoptotic targets not defined"]},{"year":2007,"claim":"Showed E2A and HEB act redundantly/jointly to enforce the thymic pre-TCR checkpoint and induce pre-Talpha, formalizing E protein dosage control of T-cell development.","evidence":"Double conditional knockout mice, cell-cycle and pre-Talpha analysis, IL-7 stimulation","pmids":["17442955"],"confidence":"High","gaps":["Distinct vs shared targets of E2A and HEB not separated","Mechanism of IL-7-driven proliferation increase unclear"]},{"year":2006,"claim":"Implicated E2A in antibody diversification by showing it stimulates Ig hypermutation, inferring recruitment of AID to Ig loci.","evidence":"E2A inactivation and complementation in DT40 cells, hypermutation frequency assay","pmids":["16785535"],"confidence":"Medium","gaps":["AID recruitment inferred, not directly demonstrated","Single chicken B-cell model"]},{"year":2006,"claim":"Showed Tcf3 reactivation in committed epidermal cells re-imposes an undifferentiated, Wnt-inhibited stem-cell-like program repressing all skin lineages, establishing it as a master stemness factor in skin.","evidence":"Inducible transgenic gain-of-function, expression profiling","pmids":["17018284"],"confidence":"High","gaps":["Direct vs indirect target separation incomplete","Corepressor dependence not dissected in this study"]},{"year":2010,"claim":"Identified the switch that derepresses TCF3 targets, showing Wnt recruits HIPK2 via beta-catenin to phosphorylate TCF3 and dissociate it from promoters during axis specification.","evidence":"Xenopus/mammalian phosphorylation assays, ChIP, phospho-resistant mutants, developmental readouts","pmids":["20951344"],"confidence":"High","gaps":["Phosphosites and their generality across loci not fully mapped","Conservation in mammalian stem cells not tested here"]},{"year":2011,"claim":"Reframed Wnt action in ESCs by showing relief of TCF3 repression — not TCF3-beta-catenin activation — is the necessary downstream effect for self-renewal.","evidence":"Tcf3 knockout, epistasis with Wnt3a/GSK3 inhibitor, ChIP at Oct4 sites","pmids":["21685894"],"confidence":"High","gaps":["Full repressed target set not enumerated","Quantitative contribution of Tcf1 cooperation unresolved"]},{"year":2011,"claim":"Tied Tcf3 repression to chromatin state, showing its loss alters genome-wide histone marks and enhances reprogramming of somatic cells.","evidence":"Tcf3 knockout ESCs, ChIP for AcH3/H3K9me3, cell-fusion reprogramming assay","pmids":["21730189"],"confidence":"Medium","gaps":["Direct vs secondary chromatin effects not separated","Enzymes mediating mark changes not identified"]},{"year":2011,"claim":"Resolved the corepressor logic of Tcf3 repression, showing direct cdx4 repression requires Groucho/TLE and HDAC1, and is relieved by corepressor displacement without DNA dissociation.","evidence":"ChIP, reporter assays, co-IP, in vivo zebrafish and mammalian cell perturbation","pmids":["21666599"],"confidence":"Medium","gaps":["Generality of corepressor-displacement mechanism beyond cdx4 untested","Single lab/model"]},{"year":2011,"claim":"Identified Foxo1 as a direct E2A target at the earliest stage of B-cell specification, placing E2A atop the specification hierarchy with HEB.","evidence":"ChIP at FOXO1 locus, expression in E2A/HEB-deficient CLPs, compound knockouts","pmids":["21972416"],"confidence":"High","gaps":["Relative contributions of multiple enhancers not weighted","Downstream Foxo1 dependence not formally tested"]},{"year":2011,"claim":"Linked TCF3 to leukemic surface phenotype by showing genotype-dependent E2A binding controls CD38 transcription in CLL.","evidence":"ChIP, siRNA knockdown, flow cytometry in CLL cells","pmids":["21212793"],"confidence":"Medium","gaps":["Mechanistic basis for allele-specific binding not fully resolved","Single cell-type context"]},{"year":2012,"claim":"Distinguished beta-catenin-dependent from -independent TCF3 functions in vivo and defined an indirect Wnt activation route via TCF3 repression of Lef1.","evidence":"Tcf3-deltaN knock-in mouse ablating beta-catenin interaction, genetic and expression analysis","pmids":["22573616"],"confidence":"High","gaps":["Direct Tcf3 targets beyond Lef1 not enumerated","Mechanism of stage-specific requirement unclear"]},{"year":2013,"claim":"Placed E2A in T-cell commitment by showing it limits Gata3 to enable lineage progression in DN2 thymocytes.","evidence":"E2A conditional knockout, Gata3 siRNA rescue, differentiation assays","pmids":["23297135"],"confidence":"High","gaps":["Direct vs indirect repression of Gata3 not established","Other commitment targets not addressed"]},{"year":2013,"claim":"Generalized E2A's cell-cycle role to cancer by showing it shapes p53 target-gene selectivity (activating p21, repressing PUMA).","evidence":"Genome-wide siRNA screen, expression, cell-cycle/apoptosis assays in multiple cancer lines","pmids":["23684607"],"confidence":"Medium","gaps":["Direct vs indirect regulation of PUMA not clarified","Mechanism of p53 cooperation unresolved"]},{"year":2013,"claim":"Extended TCF3's promoter-occupancy role to hormone signaling, showing constitutive TCF3 occupancy at Lhcgr is required for FSH-induced expression in granulosa cells.","evidence":"ChIP, dominant-negative TCF, reporter assay, microarray","pmids":["23754802"],"confidence":"Medium","gaps":["Dominant-negative may affect multiple TCFs","Direct TCF3-specific requirement not isolated"]},{"year":2014,"claim":"Revealed a non-cell-autonomous, beta-catenin-independent role for Tcf3 in wound repair via Stat3-driven induction of secreted lipocalin-2.","evidence":"Overexpression, wound healing/conditioned-medium assays, lipocalin-2 neutralization, Stat3 epistasis","pmids":["24909826"],"confidence":"Medium","gaps":["Direct vs indirect lipocalin-2 regulation not resolved","In vivo wound contribution single-lab"]},{"year":2014,"claim":"Confirmed at the cellular level that Tcf3-expressing bulge cells are bona fide self-renewing multipotent stem cells across stratified epithelia.","evidence":"Tcf3-CreER knock-in lineage tracing","pmids":["25038042"],"confidence":"Medium","gaps":["Descriptive lineage marking, not mechanistic","Single lab"]},{"year":2015,"claim":"Demonstrated the TCF3-to-TCF4 exchange paradigm at a Wnt target, showing TCF3 represses MYC until beta-catenin activation swaps in TCF4 to drive cell-cycle re-entry.","evidence":"ChIP, shRNA of TCF3/TCF4, reporters, GSK3beta inhibition, cell-cycle analysis in colorectal cells","pmids":["25659031"],"confidence":"Medium","gaps":["Kinetics of factor exchange not resolved","Single cancer-cell context"]},{"year":2018,"claim":"Established splicing as a regulatory layer, showing hnRNP H/F control the E12/E47 isoform switch with isoform-specific functional outputs (E47 represses E-cadherin) tied to pluripotency.","evidence":"hnRNP H/F knockdown, isoform-specific assays, E-cadherin readout in hESCs","pmids":["30115631"],"confidence":"High","gaps":["Genome-wide isoform-specific target differences not mapped","Mechanism of E-cadherin repression specificity unclear"]},{"year":2020,"claim":"Defined distinct lineage-specific cis-elements through which E2A activates Rag genes, with E2A E-box binding essential for chromatin remodeling in T cells.","evidence":"Enhancer-deletion and binding-site point-mutant knock-in mice, chromatin conformation, expression","pmids":["32887843"],"confidence":"High","gaps":["Cofactors mediating remodeling at R-TEn not identified","B-cell element mechanism less fully dissected"]},{"year":2021,"claim":"Extended E2A activator function to CD8 memory, showing it remodels enhancers of memory genes to bias memory precursor formation.","evidence":"scRNA-seq, GRN analysis, ATAC-seq, E2A ChIP/overexpression","pmids":["33859041"],"confidence":"Medium","gaps":["Direct target enhancers driving phenotype not pinpointed","Loss-of-function complement not shown"]},{"year":2021,"claim":"Placed TCF3 downstream of epigenetic silencing in cancer, defining an EZH2/DNMT3B->TCF3->p21 tumor-suppressive axis in endometrial cancer.","evidence":"H3K27me3 ChIP, bisulfite sequencing, TCF3 reporter, inhibitors in CDX/PDX models","pmids":["34175897"],"confidence":"Medium","gaps":["Direct vs indirect TCF3 silencing contributions not weighted","Single-lab cancer context"]},{"year":2022,"claim":"Linked metabolic and proteostatic control to TCF3, showing SHMT2/mTOR inhibition triggers autophagic TCF3 degradation that collapses tonic BCR signaling essential for Burkitt lymphoma survival.","evidence":"CRISPR screen, SHMT2 knockdown, pharmacology, mTOR analysis, TCF3 protein measurement","pmids":["34624079"],"confidence":"Medium","gaps":["Autophagy machinery selectivity for TCF3 not defined","How TCF3 controls tonic BCR mechanistically unresolved"]},{"year":2024,"claim":"Uncovered an Id2-LSD1 epigenetic axis acting on Tcf3, where Id2 disrupts a Tcf3-LSD1 complex to preserve H3K4me2 at Tcf3 E-boxes, controlling progenitor exhausted CD8 T cell generation.","evidence":"Co-IP, H3K4me2 ChIP, Id2 knockout, LSD1 inhibitor rescue, Id2 HLH mutant","pmids":["38287103"],"confidence":"Medium","gaps":["Direct Tcf3-LSD1 contact interface not mapped","Generality beyond Slamf6 locus untested"]},{"year":2024,"claim":"Extended TCF3's developmental regulatory role to oogenesis, showing TCF3/TCF12 control enhancer-driven activation of oocyte genes and folliculogenesis.","evidence":"H3K27ac ChIP-seq in oocytes, TCF3 knockout, expression analysis","pmids":["38839978"],"confidence":"Medium","gaps":["Direct vs indirect target genes not separated","Single lab"]},{"year":null,"claim":"How the activator versus repressor switch of TCF3 is selected at a given locus and cell state — integrating partner choice, isoform, acetylation/degradation, corepressor occupancy, and Wnt signaling into a predictive logic — remains unresolved.","evidence":"No single study in the timeline integrates these regulatory layers into a unified mechanistic model","pmids":[],"confidence":"Low","gaps":["No structural model of TCF3 at native chromatin with cofactors","Quantitative rules governing activator-to-repressor switching are undefined","Crosstalk between degradation, acetylation, and splicing inputs not integrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,7,8,11,33]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,15,18,19,20,27]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,15,33]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[6,9]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,15,18,33]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,13,14,28,29,32]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,10,11,12,35]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1,14,22,29,35]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[7,8,12,38,39]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[24,25,31]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[3,4,5,6,34]}],"complexes":["E2A-HEB bHLH heterodimer","Tcf3-Groucho/TLE-HDAC1 corepressor complex","SCF(Skp2)-CHIP-Hsc70 E2A pre-ubiquitination complex"],"partners":["HEB","EBF1","LYL1","SKP2","CHIP","P300","HIPK2","BETA-CATENIN"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9HCS4","full_name":"Transcription factor 7-like 1","aliases":["HMG box transcription factor 3","TCF-3"],"length_aa":588,"mass_kda":62.6,"function":"Participates in the Wnt signaling pathway. Binds to DNA and acts as a repressor in the absence of CTNNB1, and as an activator in its presence. Necessary for the terminal differentiation of epidermal cells, the formation of keratohyalin granules and the development of the barrier function of the epidermis (By similarity). Down-regulates NQO1, leading to increased mitomycin c resistance","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9HCS4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TCF3","classification":"Not Classified","n_dependent_lines":38,"n_total_lines":1208,"dependency_fraction":0.03145695364238411},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TCF3","total_profiled":1310},"omim":[{"mim_id":"620809","title":"ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 5; ASCL5","url":"https://www.omim.org/entry/620809"},{"mim_id":"619824","title":"AGAMMAGLOBULINEMIA 8B, AUTOSOMAL RECESSIVE; AGM8B","url":"https://www.omim.org/entry/619824"},{"mim_id":"618819","title":"PBX HOMEOBOX-INTERACTING PROTEIN 1; PBXIP1","url":"https://www.omim.org/entry/618819"},{"mim_id":"617578","title":"FER3-LIKE bHLH TRANSCRIPTION FACTOR; FERD3L","url":"https://www.omim.org/entry/617578"},{"mim_id":"616941","title":"AGAMMAGLOBULINEMIA 8A, AUTOSOMAL DOMINANT; AGM8A","url":"https://www.omim.org/entry/616941"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TCF3"},"hgnc":{"alias_symbol":["E2A","ITF1","MGC129647","MGC129648","bHLHb21","VDIR","E47","p75"],"prev_symbol":[]},"alphafold":{"accession":"Q9HCS4","domains":[{"cath_id":"1.10.30.10","chopping":"348-415","consensus_level":"medium","plddt":92.5981,"start":348,"end":415}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCS4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCS4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCS4-F1-predicted_aligned_error_v6.png","plddt_mean":51.78},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TCF3","jax_strain_url":"https://www.jax.org/strain/search?query=TCF3"},"sequence":{"accession":"Q9HCS4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9HCS4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9HCS4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCS4"}},"corpus_meta":[{"pmid":"8001125","id":"PMC_8001125","title":"E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements.","date":"1994","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8001125","citation_count":633,"is_preprint":false},{"pmid":"8001124","id":"PMC_8001124","title":"The helix-loop-helix gene E2A is required for B cell formation.","date":"1994","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8001124","citation_count":559,"is_preprint":false},{"pmid":"11445543","id":"PMC_11445543","title":"Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11445543","citation_count":442,"is_preprint":false},{"pmid":"20952688","id":"PMC_20952688","title":"Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20952688","citation_count":307,"is_preprint":false},{"pmid":"9315646","id":"PMC_9315646","title":"Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9315646","citation_count":285,"is_preprint":false},{"pmid":"21685894","id":"PMC_21685894","title":"Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21685894","citation_count":252,"is_preprint":false},{"pmid":"10435576","id":"PMC_10435576","title":"Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10435576","citation_count":250,"is_preprint":false},{"pmid":"17018284","id":"PMC_17018284","title":"Tcf3 governs stem cell features and represses cell fate determination in skin.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17018284","citation_count":246,"is_preprint":false},{"pmid":"9372963","id":"PMC_9372963","title":"High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9372963","citation_count":202,"is_preprint":false},{"pmid":"11248806","id":"PMC_11248806","title":"SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.","date":"2000","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11248806","citation_count":184,"is_preprint":false},{"pmid":"8104101","id":"PMC_8104101","title":"Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8104101","citation_count":183,"is_preprint":false},{"pmid":"9405651","id":"PMC_9405651","title":"Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9405651","citation_count":167,"is_preprint":false},{"pmid":"6854740","id":"PMC_6854740","title":"Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b.","date":"1983","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/6854740","citation_count":158,"is_preprint":false},{"pmid":"2000219","id":"PMC_2000219","title":"Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system.","date":"1991","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2000219","citation_count":158,"is_preprint":false},{"pmid":"14592976","id":"PMC_14592976","title":"Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14592976","citation_count":152,"is_preprint":false},{"pmid":"8497267","id":"PMC_8497267","title":"E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8497267","citation_count":143,"is_preprint":false},{"pmid":"7791786","id":"PMC_7791786","title":"Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7791786","citation_count":136,"is_preprint":false},{"pmid":"20951344","id":"PMC_20951344","title":"Regulation of TCF3 by Wnt-dependent phosphorylation during vertebrate axis specification.","date":"2010","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/20951344","citation_count":133,"is_preprint":false},{"pmid":"11524435","id":"PMC_11524435","title":"Physiological regulation of [beta]-catenin stability by Tcf3 and CK1epsilon.","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11524435","citation_count":126,"is_preprint":false},{"pmid":"15030778","id":"PMC_15030778","title":"Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent.","date":"2004","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15030778","citation_count":117,"is_preprint":false},{"pmid":"10933599","id":"PMC_10933599","title":"E2A proteins: essential regulators at multiple stages of B-cell development.","date":"2000","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/10933599","citation_count":99,"is_preprint":false},{"pmid":"27213691","id":"PMC_27213691","title":"Id2 reinforces TH1 differentiation and inhibits E2A to repress TFH differentiation.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27213691","citation_count":99,"is_preprint":false},{"pmid":"8356060","id":"PMC_8356060","title":"Localization of E2A mRNA expression in developing and adult rat tissues.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8356060","citation_count":97,"is_preprint":false},{"pmid":"17442955","id":"PMC_17442955","title":"E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17442955","citation_count":94,"is_preprint":false},{"pmid":"14685278","id":"PMC_14685278","title":"E2A proteins enforce a proliferation checkpoint in developing thymocytes.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14685278","citation_count":94,"is_preprint":false},{"pmid":"22573616","id":"PMC_22573616","title":"Function of Wnt/β-catenin in counteracting Tcf3 repression through the Tcf3-β-catenin interaction.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22573616","citation_count":91,"is_preprint":false},{"pmid":"9032278","id":"PMC_9032278","title":"E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9032278","citation_count":88,"is_preprint":false},{"pmid":"9584174","id":"PMC_9584174","title":"Functional replacement of the mouse E2A gene with a human HEB cDNA.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9584174","citation_count":88,"is_preprint":false},{"pmid":"9927682","id":"PMC_9927682","title":"Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9927682","citation_count":87,"is_preprint":false},{"pmid":"31031137","id":"PMC_31031137","title":"Complementary Activity of ETV5, RBPJ, and TCF3 Drives Formative Transition from Naive Pluripotency.","date":"2019","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/31031137","citation_count":85,"is_preprint":false},{"pmid":"12446773","id":"PMC_12446773","title":"Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12446773","citation_count":82,"is_preprint":false},{"pmid":"15078898","id":"PMC_15078898","title":"Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15078898","citation_count":74,"is_preprint":false},{"pmid":"11784864","id":"PMC_11784864","title":"Gradient of E2A activity in B-cell development.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11784864","citation_count":72,"is_preprint":false},{"pmid":"24909826","id":"PMC_24909826","title":"Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24909826","citation_count":68,"is_preprint":false},{"pmid":"24920014","id":"PMC_24920014","title":"A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24920014","citation_count":66,"is_preprint":false},{"pmid":"21972416","id":"PMC_21972416","title":"The transcription factors E2A and HEB act in concert to induce the expression of FOXO1 in the common lymphoid progenitor.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21972416","citation_count":65,"is_preprint":false},{"pmid":"7540882","id":"PMC_7540882","title":"Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.","date":"1995","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7540882","citation_count":64,"is_preprint":false},{"pmid":"23754802","id":"PMC_23754802","title":"Lhcgr expression in granulosa cells: roles for PKA-phosphorylated β-catenin, TCF3, and FOXO1.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23754802","citation_count":64,"is_preprint":false},{"pmid":"12435739","id":"PMC_12435739","title":"Regulation of E2A activities by histone acetyltransferases in B lymphocyte development.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12435739","citation_count":63,"is_preprint":false},{"pmid":"30115631","id":"PMC_30115631","title":"TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/30115631","citation_count":62,"is_preprint":false},{"pmid":"23684607","id":"PMC_23684607","title":"A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23684607","citation_count":60,"is_preprint":false},{"pmid":"30778199","id":"PMC_30778199","title":"HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.","date":"2019","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/30778199","citation_count":59,"is_preprint":false},{"pmid":"24832538","id":"PMC_24832538","title":"Tcf3 represses Wnt-β-catenin signaling and maintains neural stem cell population during neocortical development.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24832538","citation_count":56,"is_preprint":false},{"pmid":"15456869","id":"PMC_15456869","title":"Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15456869","citation_count":56,"is_preprint":false},{"pmid":"9013644","id":"PMC_9013644","title":"Degradation of E2A proteins through a ubiquitin-conjugating enzyme, UbcE2A.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9013644","citation_count":56,"is_preprint":false},{"pmid":"10594029","id":"PMC_10594029","title":"Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10594029","citation_count":55,"is_preprint":false},{"pmid":"16428437","id":"PMC_16428437","title":"E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16428437","citation_count":53,"is_preprint":false},{"pmid":"23297135","id":"PMC_23297135","title":"E2A transcription factors limit expression of Gata3 to facilitate T lymphocyte lineage commitment.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23297135","citation_count":53,"is_preprint":false},{"pmid":"21730189","id":"PMC_21730189","title":"T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21730189","citation_count":50,"is_preprint":false},{"pmid":"8628307","id":"PMC_8628307","title":"Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8628307","citation_count":50,"is_preprint":false},{"pmid":"16785535","id":"PMC_16785535","title":"E2A expression stimulates Ig hypermutation.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16785535","citation_count":49,"is_preprint":false},{"pmid":"17311319","id":"PMC_17311319","title":"Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia.","date":"2007","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17311319","citation_count":49,"is_preprint":false},{"pmid":"32887843","id":"PMC_32887843","title":"The transcription factor E2A activates multiple enhancers that drive Rag expression in developing T and B cells.","date":"2020","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32887843","citation_count":49,"is_preprint":false},{"pmid":"27461063","id":"PMC_27461063","title":"Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.","date":"2016","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/27461063","citation_count":47,"is_preprint":false},{"pmid":"31735627","id":"PMC_31735627","title":"The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability.","date":"2019","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/31735627","citation_count":46,"is_preprint":false},{"pmid":"22564737","id":"PMC_22564737","title":"Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22564737","citation_count":45,"is_preprint":false},{"pmid":"17604208","id":"PMC_17604208","title":"E2A proteins: regulators of cell phenotype in normal physiology and disease.","date":"2007","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17604208","citation_count":44,"is_preprint":false},{"pmid":"38839978","id":"PMC_38839978","title":"Mapping putative enhancers in mouse oocytes and early embryos reveals TCF3/12 as key folliculogenesis regulators.","date":"2024","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/38839978","citation_count":43,"is_preprint":false},{"pmid":"9665477","id":"PMC_9665477","title":"Restricted expression of E2A protein in primary human tissues correlates with proliferation and differentiation.","date":"1998","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9665477","citation_count":42,"is_preprint":false},{"pmid":"25659031","id":"PMC_25659031","title":"A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.","date":"2015","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25659031","citation_count":42,"is_preprint":false},{"pmid":"28209658","id":"PMC_28209658","title":"Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.","date":"2017","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/28209658","citation_count":42,"is_preprint":false},{"pmid":"34624079","id":"PMC_34624079","title":"SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34624079","citation_count":41,"is_preprint":false},{"pmid":"34175897","id":"PMC_34175897","title":"TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34175897","citation_count":41,"is_preprint":false},{"pmid":"11490000","id":"PMC_11490000","title":"E2A and HEB activate the pre-TCR alpha promoter during immature T cell development.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11490000","citation_count":41,"is_preprint":false},{"pmid":"15555546","id":"PMC_15555546","title":"Snail regulates p21(WAF/CIP1) expression in cooperation with E2A and Twist.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15555546","citation_count":39,"is_preprint":false},{"pmid":"11486032","id":"PMC_11486032","title":"The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11486032","citation_count":38,"is_preprint":false},{"pmid":"12700034","id":"PMC_12700034","title":"E2A basic helix-loop-helix transcription factors in human leukemia.","date":"2003","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/12700034","citation_count":35,"is_preprint":false},{"pmid":"32276273","id":"PMC_32276273","title":"E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.","date":"2020","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/32276273","citation_count":35,"is_preprint":false},{"pmid":"15882343","id":"PMC_15882343","title":"B cells, E2A, and aging.","date":"2005","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15882343","citation_count":34,"is_preprint":false},{"pmid":"12457613","id":"PMC_12457613","title":"Regulation of early lymphocyte development by E2A family proteins.","date":"2002","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12457613","citation_count":33,"is_preprint":false},{"pmid":"21072044","id":"PMC_21072044","title":"The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.","date":"2010","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/21072044","citation_count":33,"is_preprint":false},{"pmid":"21212793","id":"PMC_21212793","title":"E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia.","date":"2011","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/21212793","citation_count":33,"is_preprint":false},{"pmid":"10216071","id":"PMC_10216071","title":"Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10216071","citation_count":32,"is_preprint":false},{"pmid":"34728784","id":"PMC_34728784","title":"Decreased expression of ATF3, orchestrated by β-catenin/TCF3, miR-17-5p and HOXA11-AS, promoted gastric cancer progression via increased β-catenin and CEMIP.","date":"2021","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34728784","citation_count":32,"is_preprint":false},{"pmid":"33859041","id":"PMC_33859041","title":"E2A-regulated epigenetic landscape promotes memory CD8 T cell differentiation.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33859041","citation_count":31,"is_preprint":false},{"pmid":"27758892","id":"PMC_27758892","title":"E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27758892","citation_count":31,"is_preprint":false},{"pmid":"27538704","id":"PMC_27538704","title":"MicroRNA-506-3p regulates neural stem cell proliferation and differentiation through targeting TCF3.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/27538704","citation_count":30,"is_preprint":false},{"pmid":"9032268","id":"PMC_9032268","title":"Cell transformation mediated by homodimeric E2A-HLF transcription factors.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9032268","citation_count":30,"is_preprint":false},{"pmid":"38287103","id":"PMC_38287103","title":"Id2 epigenetically controls CD8+ T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex.","date":"2024","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38287103","citation_count":29,"is_preprint":false},{"pmid":"29694893","id":"PMC_29694893","title":"SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29694893","citation_count":29,"is_preprint":false},{"pmid":"16888011","id":"PMC_16888011","title":"E2A promotes the survival of precursor and mature B lymphocytes.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16888011","citation_count":29,"is_preprint":false},{"pmid":"11607821","id":"PMC_11607821","title":"E2A-HLF usurps control of evolutionarily conserved survival pathways.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11607821","citation_count":28,"is_preprint":false},{"pmid":"24503810","id":"PMC_24503810","title":"Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24503810","citation_count":28,"is_preprint":false},{"pmid":"23063976","id":"PMC_23063976","title":"Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23063976","citation_count":26,"is_preprint":false},{"pmid":"24723679","id":"PMC_24723679","title":"Id2 represses E2A-mediated activation of IL-10 expression in T cells.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24723679","citation_count":26,"is_preprint":false},{"pmid":"36400009","id":"PMC_36400009","title":"Transcription factors TEAD2 and E2A globally repress acetyl-CoA synthesis to promote tumorigenesis.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/36400009","citation_count":25,"is_preprint":false},{"pmid":"25038042","id":"PMC_25038042","title":"Tcf3 expression marks both stem and progenitor cells in multiple epithelia.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25038042","citation_count":25,"is_preprint":false},{"pmid":"33542097","id":"PMC_33542097","title":"Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33542097","citation_count":25,"is_preprint":false},{"pmid":"34145034","id":"PMC_34145034","title":"E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer.","date":"2021","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34145034","citation_count":24,"is_preprint":false},{"pmid":"31402303","id":"PMC_31402303","title":"HLH-2/E2A Expression Links Stochastic and Deterministic Elements of a Cell Fate Decision during C. elegans Gonadogenesis.","date":"2019","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/31402303","citation_count":24,"is_preprint":false},{"pmid":"8479911","id":"PMC_8479911","title":"Cell-specific expression of helix-loop-helix transcription factors encoded by the E2A gene.","date":"1993","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8479911","citation_count":24,"is_preprint":false},{"pmid":"24064250","id":"PMC_24064250","title":"Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24064250","citation_count":23,"is_preprint":false},{"pmid":"11319924","id":"PMC_11319924","title":"A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.","date":"2001","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/11319924","citation_count":23,"is_preprint":false},{"pmid":"32203922","id":"PMC_32203922","title":"Redox-mediated regulation of aging and healthspan by an evolutionarily conserved transcription factor HLH-2/Tcf3/E2A.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/32203922","citation_count":22,"is_preprint":false},{"pmid":"28288968","id":"PMC_28288968","title":"Depletion of Tcf3 and Lef1 maintains mouse embryonic stem cell self-renewal.","date":"2017","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/28288968","citation_count":22,"is_preprint":false},{"pmid":"21666599","id":"PMC_21666599","title":"Modulation of Tcf3 repressor complex composition regulates cdx4 expression in zebrafish.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21666599","citation_count":22,"is_preprint":false},{"pmid":"39179932","id":"PMC_39179932","title":"Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.","date":"2024","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39179932","citation_count":21,"is_preprint":false},{"pmid":"30582201","id":"PMC_30582201","title":"DDN-AS1-miR-15a/16-TCF3 feedback loop regulates tumor progression in cervical cancer.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30582201","citation_count":21,"is_preprint":false},{"pmid":"7630627","id":"PMC_7630627","title":"B cell differentiation: role of E2A and Pax5/BSAP transcription factors.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7630627","citation_count":20,"is_preprint":false},{"pmid":"33011533","id":"PMC_33011533","title":"TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p/TNKS1BP1 axis in triple-negative breast cancer.","date":"2020","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33011533","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45716,"output_tokens":9190,"usd":0.137499,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19331,"output_tokens":9355,"usd":0.165265,"stage2_stop_reason":"end_turn"},"total_usd":0.302764,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"E2A (TCF3) gene products (E12 and E47) are required for B cell formation; E2A-null mice completely lack mature B cells with a developmental block prior to immunoglobulin DJ rearrangement, demonstrating that E2A is a central regulator of early B cell differentiation.\",\n      \"method\": \"Gene targeting/knockout in mice, flow cytometry, PCR for Ig rearrangements\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent knockout studies replicated in the same year with clear developmental phenotype and molecular markers\",\n      \"pmids\": [\"8001125\", \"8001124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"E2A transcriptionally activates the cyclin-dependent kinase inhibitor p21CIP1/WAF1 promoter through E-box elements (E1–E3) near the transcription start site, providing a mechanism for E2A-mediated growth suppression; Id1 overexpression inhibits p21 expression and accelerates cell growth.\",\n      \"method\": \"Luciferase reporter/cotransfection assays, promoter deletion/mutational analysis, endogenous p21 mRNA/protein quantification in 293T cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (reporter assay, mutagenesis, endogenous gene analysis) in a single study\",\n      \"pmids\": [\"9315646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"E2A proteins (E12 and E47) are subunits of B-cell-specific E2-box DNA-binding complexes; both E2A and E2-2 polypeptides are present in immunoglobulin enhancer-binding complexes in pre-B cells, whereas mature B cells contain only E2A products.\",\n      \"method\": \"Monoclonal antibody immunoprecipitation, mobility shift assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal immunoprecipitation with specific antibodies, independently corroborated by multiple labs\",\n      \"pmids\": [\"8497267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Notch signaling induces degradation of E2A proteins (E12 and E47) via MAP kinase (p42/p44)-dependent phosphorylation of E47, which enhances association with the SCF(Skp2) E3 ubiquitin ligase, leading to ubiquitination and proteasome-mediated degradation; this pathway is active in B and T cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor treatment, siRNA knockdown, dominant-negative and activated kinase expression\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biochemical methods (co-IP, ubiquitination assay, kinase inhibitor, siRNA) in a single study\",\n      \"pmids\": [\"14592976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CHIP (carboxyl terminus of Hsc70-interacting protein) binds E47 through the E protein homology domains EHD2 and EHD3 and, together with Hsc70, forms a pre-ubiquitination complex with E47 and Skp2, facilitating E47 ubiquitination and proteasome-mediated degradation in a phosphorylation-dependent manner.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, siRNA knockdown, ubiquitination assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (yeast two-hybrid, co-IP, siRNA, ubiquitination assay) in a single focused study\",\n      \"pmids\": [\"15456869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"E2A proteins (E12/E47) are degraded via the ubiquitin-proteasome pathway; UbcE2A (a ubiquitin-conjugating enzyme) interacts specifically with a 54-amino acid region of E47 distinct from the HLH domain, and antisense UbcE2A reduces E12 degradation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, proteasome inhibitor (MG132), in vivo ubiquitination, antisense RNA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (yeast two-hybrid, proteasome inhibitor, in vivo ubiquitination, antisense rescue) in a single study\",\n      \"pmids\": [\"9013644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"E2A co-elutes with histone acetyltransferases p300, CBP, and PCAF in pre-B cell nuclear extracts; these HATs acetylate E2A in vitro, enhance E2A-mediated transcription, and promote nuclear retention of E2A; genetic interaction between E2A and p300 heterozygosity impairs B cell development.\",\n      \"method\": \"Gel filtration, co-immunoprecipitation, in vitro acetylation assay, transcription reporter assay, p300 catalytic mutant, compound heterozygous mouse crosses\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro acetylation assay plus co-IP plus genetic epistasis and catalytic mutant, single lab\",\n      \"pmids\": [\"12435739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Tcf3 acts independently of its β-catenin-interacting domain to suppress epidermal terminal differentiation and promote outer root sheath/bulge stem cell identity in skin; these functions are dependent on Tcf3's DNA-binding and Groucho repressor-binding domains.\",\n      \"method\": \"Transgenic mouse overexpression with domain deletion constructs, keratinocyte differentiation markers\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain dissection in transgenic mice with multiple differentiation readouts, single lab\",\n      \"pmids\": [\"11445543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Tcf3 governs stem cell features in skin; forced reactivation of Tcf3 in committed epidermal cells induces genes associated with an undifferentiated, Wnt-inhibited state and represses transcriptional regulators of all three skin differentiation lineages (epidermal, sebaceous, hair follicle).\",\n      \"method\": \"Inducible transgenic mouse system, gene expression profiling\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible gain-of-function in vivo with multiple differentiation lineage readouts\",\n      \"pmids\": [\"17018284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Wnt signaling stimulates TCF3 phosphorylation by recruiting HIPK2 (homeodomain-interacting protein kinase 2) to TCF3 via β-catenin; this phosphorylation causes TCF3 dissociation from target gene promoters, derepressing Wnt target genes during anteroposterior axis specification in Xenopus.\",\n      \"method\": \"Xenopus embryo and mammalian cell phosphorylation assays, chromatin immunoprecipitation, phosphorylation-resistant TCF3 mutants, developmental gene expression readouts\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — biochemical phosphorylation assay, ChIP, structure-function with point mutants, functional developmental rescue\",\n      \"pmids\": [\"20951344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Tcf3 can inhibit β-catenin turnover by competing with axin and APC for β-catenin binding; Tcf3 is phosphorylated by both GSK3 and CK1ε, with CK1ε phosphorylation stimulating Tcf3–β-catenin binding (reversed by GSK3), and Tcf3 synergizes with CK1ε to stabilize β-catenin.\",\n      \"method\": \"Xenopus embryo and extract biochemistry, β-catenin degradation assays, dominant-negative constructs, peptide competition\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in Xenopus extracts with multiple competing biochemical methods, single lab\",\n      \"pmids\": [\"11524435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tcf3 functions as a transcriptional repressor in ESCs; genetic ablation of Tcf3 replaces the requirement for exogenous Wnt3a or GSK3 inhibition for ESC self-renewal, demonstrating that relief of Tcf3-mediated repression (not Tcf3–β-catenin transcriptional activation) is the necessary downstream effect of Wnt signaling; Tcf3 and Tcf1 together recruit Wnt-stabilized β-catenin to Oct4 binding sites.\",\n      \"method\": \"Genetic knockout, gene expression analysis, ChIP, Wnt3a treatment, GSK3 inhibitor treatment\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic ablation with multiple epistasis readouts, ChIP, single lab\",\n      \"pmids\": [\"21685894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Tcf3–β-catenin interaction is not required for gastrulation but is required for post-gastrulation development (limb, vascular, neural tube, eyelid); Tcf3 directly represses Lef1 transcription, and Wnt/β-catenin counteracts this repression, allowing Lef1–β-catenin complexes to activate target genes (indirect activation mechanism).\",\n      \"method\": \"Tcf3ΔN knock-in mouse (ablates β-catenin interaction), genetic analysis, gene expression\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — precise domain knock-in in vivo with developmental and molecular phenotype characterization\",\n      \"pmids\": [\"22573616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"EBF and E2A synergistically activate transcription of B-cell-specific genes including Pax5, Rag1, Rag2, and mb-1; Ebf+/−E2a+/− compound heterozygous mice show a marked pro-B cell defect greater than either single heterozygote, demonstrating genetic collaboration in B lymphopoiesis.\",\n      \"method\": \"Compound heterozygous mouse genetics, gene expression analysis, transfection synergy assay\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with compound heterozygotes and cellular transcription assays\",\n      \"pmids\": [\"10435576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"E2A is required for the complete cell-cycle arrest observed at the pre-TCR checkpoint; E2A-deficient thymocytes exhibit abnormal cell-cycle progression prior to pre-TCR expression, and E47 can act in concert with Bcl-2 to induce cell-cycle arrest in vitro.\",\n      \"method\": \"E2A conditional knockout, cell-cycle analysis, double-mutant epistasis (LAT, Lck, Fyn), in vitro cell-cycle arrest assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in vivo plus in vitro functional assay, single lab\",\n      \"pmids\": [\"14685278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"E2A directly activates chromatin modification and germ-line transcription at the immunoglobulin kappa locus in pre-B cells; E2A binds the κEi and κE3' enhancers, and induction of E47 in E2A-deficient pre-B cells rescues Igκ germ-line transcription, Jκ accessibility, and V(D)J recombination; IRF-4 is required for E2A recruitment to κE3'.\",\n      \"method\": \"E2A-deficient pre-B cells, inducible E47 reconstitution, chromatin immunoprecipitation, recombination assay, IRF-4 knockdown\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reconstitution in knockout cells with ChIP and functional recombination readout\",\n      \"pmids\": [\"16428437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"E2A promotes survival of pre-B and mature B lymphocytes; conditional deletion of E2A in mature B cells causes rapid depletion within 24 h, and E2A/HEB double-deficient pre-B lines show dramatically enhanced apoptosis upon growth arrest.\",\n      \"method\": \"IFN-inducible Cre conditional knockout, adoptive transfer, apoptosis assay in double-deficient cell lines\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional knockout with in vivo and in vitro apoptosis readouts; survival function not fully mechanistically resolved\",\n      \"pmids\": [\"15078898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"E2A expression stimulates immunoglobulin hypermutation in chicken DT40 B cells; E2A inactivation strongly reduces Ig L chain mutation rate without affecting AID expression, and re-expression of E12 or E47 complements the defect, suggesting E2A recruits AID to Ig loci.\",\n      \"method\": \"E2A gene inactivation in DT40 cells, Ig hypermutation frequency assay, cDNA complementation\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean loss-of-function with functional readout in a single chicken B cell model; AID recruitment is inferred, not directly shown\",\n      \"pmids\": [\"16785535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"E2A binds enhancer elements across the FOXO1 locus to directly activate Foxo1 expression in common lymphoid progenitors; E2A and HEB jointly induce FOXO1 at the earliest stage of B-cell specification.\",\n      \"method\": \"ChIP (E2A binding to FOXO1 locus), gene expression in E2A- and HEB-deficient CLPs, compound knockout mice\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct binding plus genetic loss-of-function in vivo with compound knockouts\",\n      \"pmids\": [\"21972416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"E2A directly activates expression of Rag genes in T and B cells through distinct sets of cis-regulatory elements (R-TEn in T cells; R1B/R2B in B cells); E2A binding to the E-box in R-TEn is essential for chromatin remodeling and Rag expression in T cells.\",\n      \"method\": \"Transgenic mice with enhancer deletions, E2A binding-site point mutation knock-in mice, chromatin conformation analysis, gene expression\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mouse strains with enhancer and binding-site mutations, chromatin accessibility readout, single lab\",\n      \"pmids\": [\"32887843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"E2A and HEB bind consecutive E-box elements in the pre-TCRα (pTα) promoter and directly activate pTα transcription; the specific E2A/HEB-DNA complex is observed exclusively in immature thymocytes and not in mature T cells.\",\n      \"method\": \"Promoter deletion analysis, EMSA, E2A/HEB overexpression, reporter assay in thymocytes\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA, reporter assay, overexpression; single lab\",\n      \"pmids\": [\"11490000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Alternative splicing of TCF3 (E2A) controlled by hnRNP H/F produces E12 and E47 isoforms; high hnRNP H/F in hESCs promotes E12, while decreased hnRNP H/F during differentiation switches to E47; E47 represses E-cadherin expression, whereas E12 does not, linking TCF3 splicing to maintenance of hESC pluripotency.\",\n      \"method\": \"siRNA knockdown of hnRNP H/F, isoform-specific expression analysis, E-cadherin reporter/expression assay, hESC differentiation\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional splicing switch with isoform-specific gain-of-function readout plus knockdown phenotype, single lab\",\n      \"pmids\": [\"30115631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TCF3/E2A drives p21 (CDKN1A) expression while repressing PUMA (BBC3) across cancer cell types; TCF3/E2A depletion impairs cell-cycle arrest and promotes apoptosis upon p53 activation, placing TCF3/E2A as a pathway-specific coregulator of p53 target gene selectivity.\",\n      \"method\": \"Genome-wide genetic screen (siRNA), gene expression analysis, cell-cycle and apoptosis assays in multiple cancer cell lines\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-scale screen validated by knockdown/phenotype assays; single lab\",\n      \"pmids\": [\"23684607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tcf3 promotes keratinocyte migration and skin wound healing non-cell-autonomously through upregulation of the secreted factor lipocalin-2; Stat3 acts as an upstream activator of Tcf3 in this wound-repair context, and Tcf3's promigration effects are independent of β-catenin binding.\",\n      \"method\": \"Tcf3 overexpression, wound healing assay, conditioned medium experiments, lipocalin-2 neutralization, Stat3 epistasis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal assays including conditioned medium rescue; single lab\",\n      \"pmids\": [\"24909826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tcf3 functions as a repressor of epigenome state in ES cells; Tcf3 deletion increases AcH3 and decreases H3K9me3 genome-wide, and Tcf3-null ES cells reprogram somatic neural precursor cells more efficiently upon cell fusion.\",\n      \"method\": \"Tcf3 knockout ES cells, chromatin immunoprecipitation for AcH3/H3K9me3, cell fusion reprogramming efficiency assay\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for histone marks in knockout cells linked to functional reprogramming readout; single lab\",\n      \"pmids\": [\"21730189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tcf3 directly represses cdx4 expression through binding multiple sites in the cdx4 regulatory region, requiring Groucho/TLE and HDAC1 as corepressors; the transcription factor E4f1 derepresses cdx4 by dissociating corepressors from Tcf3 (without displacing Tcf3 from DNA), and the E3 ligase Lnx2b counteracts E4f1 as a scaffold.\",\n      \"method\": \"ChIP, reporter assays, co-IP, dominant-negative and overexpression in zebrafish embryos and mammalian cells\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus co-IP plus in vivo functional assays; single lab, zebrafish model\",\n      \"pmids\": [\"21666599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"LYL1 forms heterodimeric complexes with E2A proteins (E12 and E47) via HLH motif interactions; endogenous LYL1–E2A complexes exist in hematolymphoid cells and bind a preferred DNA sequence (5'-AACAGATG(T/g)T-3') distinct from the muE2 site.\",\n      \"method\": \"Yeast two-hybrid, in vitro HLH interaction, immunoprecipitation, PCR-assisted site selection, EMSA\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid confirmed by co-IP and DNA binding characterization; single lab\",\n      \"pmids\": [\"8628307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"E2A basic region residues establish DNA sequence specificity for particular CAN NTG E-box sites through the conformation of the basic region–DNA interaction; the E2A basic region can be directed toward different half-sites depending on its heterodimerization partner (e.g., MyoD or Twist).\",\n      \"method\": \"In vitro DNA binding assays with basic region mutants, site selection, heterodimer formation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — systematic mutagenesis plus in vitro DNA binding; single lab, no in vivo validation\",\n      \"pmids\": [\"10594029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"E2A transcription factors limit expression of Gata3 in DN2 thymocytes to enable T-lymphocyte commitment; genetic or siRNA-mediated reduction of Gata3 rescues T-cell differentiation in E2A-deficient DN2 cells, placing E2A upstream of Gata3 in the T-cell commitment pathway.\",\n      \"method\": \"E2A conditional knockout, siRNA of Gata3, flow cytometry, differentiation assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis confirmed by siRNA rescue with clear cellular phenotype readout\",\n      \"pmids\": [\"23297135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Simultaneous conditional deletion of E2A and HEB in developing thymocytes causes a severe developmental block before pre-TCR expression and dramatic reduction of Pre-Tα expression, with increased IL-7-driven proliferation; E2A and HEB together enforce cell-cycle arrest prior to pre-TCR expression.\",\n      \"method\": \"Double conditional knockout mice (Cre-mediated), cell-cycle analysis, IL-7 stimulation, pre-Tα expression analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — double conditional knockout with multiple functional and molecular readouts\",\n      \"pmids\": [\"17442955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EZH2 epigenetically represses TCF3 expression (via H3K27 trimethylation), and DNMT3B independently methylates the TCF3 promoter to silence TCF3; TCF3 in turn directly activates CDKN1A (p21) transcription, establishing an EZH2/DNMT3B→TCF3→p21 axis in endometrial cancer.\",\n      \"method\": \"ChIP for H3K27me3, bisulfite sequencing of TCF3 promoter, TCF3 reporter assay, pharmacological inhibitors (GSK126, 5-Aza) in CDX and PDX models\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, DNA methylation mapping, functional rescue; single lab\",\n      \"pmids\": [\"34175897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Id2 disrupts assembly of a Tcf3–LSD1 complex (via its HLH domain binding Tcf3), thereby preventing LSD1-mediated removal of H3K4me2 from Tcf3-occupied E-boxes in the Slamf6 promoter; this epigenetic mechanism regulates the generation of Slamf6+ progenitor exhausted CD8+ T cells.\",\n      \"method\": \"Co-immunoprecipitation, ChIP for H3K4me2, Id2 knockout, LSD1 inhibitor rescue, Id2 HLH domain mutant\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, ChIP, domain mutant, pharmacological rescue; single lab\",\n      \"pmids\": [\"38287103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"E2A directly regulates chromatin accessibility at enhancers of memory-related genes in CD8+ T cells; E2A overexpression increases the frequency of memory precursor effector cells and accelerates memory cell formation while decreasing short-lived effectors.\",\n      \"method\": \"Single-cell transcriptomics, gene regulatory network analysis, ATAC-seq, E2A ChIP/overexpression\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ATAC-seq + ChIP + overexpression phenotype; single lab\",\n      \"pmids\": [\"33859041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"E2A functions as a transcriptional activator predominantly by inducing open chromatin at target genes in pro-B, small pre-B, and immature B cells; acute protein degradation (dTAG) in vivo identifies E2A as required for Rag1, Rag2, Dntt, Irf4, and Irf8 activation as direct target genes.\",\n      \"method\": \"Auxin-inducible/dTAG acute protein degradation in mice, ChIP-seq, ATAC-seq, RNA-seq\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — acute in vivo protein degradation with chromatin accessibility and transcriptome profiling; rigorous design\",\n      \"pmids\": [\"39179932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SHMT2 inhibition reduces intracellular glycine/formate, inhibits mTOR, and triggers autophagic degradation of TCF3 in Burkitt lymphoma cells; loss of TCF3 collapses tonic BCR signaling, which TCF3 controls and which is essential for BL cell survival.\",\n      \"method\": \"CRISPR-Cas9 screen, SHMT2 knockdown, pharmacological inhibition, mTOR pathway analysis, TCF3 protein level measurement\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR screen validated by mechanistic follow-up; mTOR–autophagy–TCF3 axis established in single lab\",\n      \"pmids\": [\"34624079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TCF3 binds the MYC 3' Wnt-responsive element (WRE) to repress MYC in colorectal cancer cells; Wnt/β-catenin activation (via GSK3β inhibition) causes exchange of TCF3 for TCF4/β-catenin complexes at this element, activating MYC expression as quiescent cells re-enter the cell cycle.\",\n      \"method\": \"ChIP, shRNA knockdown of TCF3, TCF4, reporter assays, GSK3β inhibitor treatment, cell-cycle analysis\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct binding plus functional knockdown with MYC expression and cell-cycle readout; single lab\",\n      \"pmids\": [\"25659031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TCF3 is constitutively associated with the Lhcgr promoter in granulosa cells, and dominant-negative TCF abolishes FSH-induced Lhcgr mRNA expression; PKA-phosphorylated β-catenin (Ser552/675) and SF1 occupy the Lhcgr promoter upon FSH treatment.\",\n      \"method\": \"Chromatin immunoprecipitation, dominant-negative TCF adenovirus, Lhcgr-luciferase reporter assay, microarray\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP showing direct promoter occupancy plus reporter and dominant-negative functional assays; single lab\",\n      \"pmids\": [\"23754802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"E2A directly interacts with CD38 regulatory E-box sequences in CLL cells (demonstrated by ChIP); E2A silencing reduces surface CD38 levels, and E2A binding is stronger at the G allele of the CD38 C→G polymorphism, linking E2A genotype-dependently to CD38 transcription.\",\n      \"method\": \"ChIP, siRNA knockdown, flow cytometry for CD38 surface expression\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus siRNA knockdown with functional readout; single lab\",\n      \"pmids\": [\"21212793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TCF3 and TCF12 are key regulators of folliculogenesis; motif analysis and loss-of-function studies in oocytes show that TCF3 deficiency impairs activation of key oocyte genes and folliculogenesis, identified through H3K27ac mapping of putative enhancers.\",\n      \"method\": \"H3K27ac ChIP-seq in oocytes, TCF3 knockout, gene expression analysis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enhancer mapping combined with knockout phenotype; single lab\",\n      \"pmids\": [\"38839978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tcf3-expressing cells in the hair follicle bulge are self-renewing multipotent stem cells in adult skin, as demonstrated by lineage tracing; Tcf3-expressing cells also mark persistent stem cells, transient progenitors, and actively differentiating cells in other stratified epithelia (paw skin, tongue, esophagus).\",\n      \"method\": \"Tcf3-CreER knock-in mouse, lineage tracing\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — lineage tracing with clean knock-in model; single lab, descriptive at the cellular level\",\n      \"pmids\": [\"25038042\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TCF3 (E2A) is a broadly expressed basic helix-loop-helix transcription factor that forms homodimers and heterodimers to bind E-box elements; it functions as a master regulator of B and T lymphocyte development by directly activating lineage-specific genes (Foxo1, Rag1/2, Igκ locus, pTα, mb-1) and enforcing cell-cycle arrest checkpoints, while its activity is regulated post-translationally by ubiquitin-proteasome degradation (via UbcE2A/SCF(Skp2)/CHIP–Hsc70 complexes, triggered by MAP kinase phosphorylation downstream of Notch), by HAT-mediated acetylation (p300/CBP/PCAF) that promotes nuclear retention and transcriptional activation, and by alternative splicing (E12 vs. E47 isoforms controlled by hnRNP H/F) with distinct functional outputs; in stem cells and development TCF3 operates primarily as a transcriptional repressor (dependent on its DNA-binding and Groucho/TLE–HDAC1 corepressor-binding domains) that maintains an undifferentiated state, and is derepressed by Wnt/β-catenin signaling through HIPK2-mediated phosphorylation that dissociates TCF3 from target promoters, or by β-catenin competition that stabilizes β-catenin while TCF3 is later replaced by activating Tcf/Lef–β-catenin complexes at Wnt target loci.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TCF3 (E2A) is a basic helix-loop-helix transcription factor that binds E-box elements as homodimers or as heterodimers with partner bHLH proteins, and it operates as a context-dependent master regulator that acts as a transcriptional activator in lymphocyte development and as a repressor in stem cells and Wnt-responsive tissues [#0, #11, #27]. In B and T lineages, E2A directly opens chromatin and activates a lineage-specific gene program — Foxo1, Rag1/Rag2, Dntt, Irf4/Irf8, the immunoglobulin kappa locus, and the pre-TCRalpha promoter — frequently in collaboration with the bHLH proteins HEB and EBF [#13, #15, #18, #20, #33], and its loss arrests B cell development before Ig DJ rearrangement [#0]. Beyond gene activation, E2A enforces cell-cycle control by transactivating the CDK inhibitor p21/CDKN1A through promoter E-boxes and by imposing the cell-cycle arrest checkpoint that precedes pre-TCR expression, while also promoting lymphocyte survival and T-lineage commitment by restraining Gata3 [#1, #14, #28, #29]. E2A activity is gated post-translationally: Notch-driven MAP-kinase phosphorylation routes E47 to SCF(Skp2)/CHIP-Hsc70-dependent ubiquitination and proteasomal degradation, p300/CBP/PCAF acetylation promotes nuclear retention and transcriptional activation, and hnRNP H/F-controlled alternative splicing partitions output between the E12 and E47 isoforms [#3, #4, #6, #21]. In stem cells and embryonic patterning, TCF3 functions as a Groucho/TLE- and HDAC1-dependent repressor that maintains an undifferentiated state and represses Wnt targets; relief of this repression — by HIPK2-mediated phosphorylation that dissociates TCF3 from promoters, by corepressor displacement, or by replacement with activating TCF/LEF-beta-catenin complexes — is the operative output of Wnt signaling [#7, #8, #9, #11, #12, #25]. TCF3 additionally tunes p53 target-gene selectivity and tonic B-cell-receptor signaling, linking it to cancer cell-cycle arrest, apoptosis, and lymphoma survival [#22, #34].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that E2A is a non-redundant master regulator of early B lymphopoiesis rather than one of many redundant bHLH factors, by showing its loss blocks B cell development before Ig rearrangement.\",\n      \"evidence\": \"Gene knockout in mice with flow cytometry and PCR of Ig rearrangements\",\n      \"pmids\": [\"8001125\", \"8001124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which direct target genes mediate the block\", \"Did not address T-lineage or non-hematopoietic roles\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Defined how E2A achieves DNA-binding specificity by showing it heterodimerizes with partner bHLH proteins (LYL1) to bind distinct preferred E-box sequences, explaining combinatorial target selection.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, PCR site selection, EMSA in hematolymphoid cells\",\n      \"pmids\": [\"8628307\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo functional consequence of LYL1-E2A complexes not established\", \"Genome-wide occupancy of these complexes unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showed at the structural level that the E2A basic region adopts partner-dependent conformations directing it to different E-box half-sites, providing a mechanism for combinatorial specificity.\",\n      \"evidence\": \"In vitro DNA binding with basic-region mutants and heterodimers (MyoD, Twist)\",\n      \"pmids\": [\"10594029\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo validation\", \"No crystal/structural model of the complex\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Connected E2A to growth suppression by identifying p21/CDKN1A as a direct E-box target and showing Id1 antagonizes this, framing E2A as a cell-cycle brake.\",\n      \"evidence\": \"Luciferase reporters, promoter mutagenesis, endogenous p21 measurement in 293T cells\",\n      \"pmids\": [\"9315646\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Done in 293T, not lymphocytes\", \"Did not address other cell-cycle targets\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Opened the post-translational regulation axis by demonstrating E2A is degraded via the ubiquitin-proteasome pathway through UbcE2A binding a discrete region of E47.\",\n      \"evidence\": \"Yeast two-hybrid, MG132 treatment, in vivo ubiquitination, antisense rescue\",\n      \"pmids\": [\"9013644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase identity not established here\", \"Signal triggering degradation unknown at this point\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified acetylation as an activating modification, showing p300/CBP/PCAF acetylate E2A to enhance transcription and nuclear retention, with genetic confirmation in B cell development.\",\n      \"evidence\": \"Gel filtration, co-IP, in vitro acetylation, reporter assay, p300 catalytic mutant, compound heterozygous mice\",\n      \"pmids\": [\"12435739\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific acetylated residues and their individual contributions not fully mapped\", \"Interplay with degradation not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined the upstream signal for E2A degradation, showing Notch-driven MAPK phosphorylation of E47 enhances SCF(Skp2) recruitment for ubiquitination, linking lineage signaling to E2A turnover.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, proteasome inhibitor, siRNA, dominant-negative/active kinase in B and T cells\",\n      \"pmids\": [\"14592976\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphosite mapping incomplete\", \"Quantitative contribution to lineage decisions in vivo not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Completed the degradation machinery model by showing CHIP and Hsc70 form a phosphorylation-dependent pre-ubiquitination complex with E47 and Skp2 via the EHD2/EHD3 domains.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, siRNA, ubiquitination assay\",\n      \"pmids\": [\"15456869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and ordering of complex assembly not determined\", \"In vivo relevance to development not tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrated E2A acts combinatorially with EBF to activate the B-lineage program (Pax5, Rag1/2, mb-1), establishing genetic collaboration rather than solo action.\",\n      \"evidence\": \"Compound heterozygous mouse genetics, expression analysis, transfection synergy\",\n      \"pmids\": [\"10435576\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct co-binding at shared enhancers not shown here\", \"Hierarchy between E2A and EBF unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Extended E2A's direct activation program to T lymphopoiesis by showing E2A/HEB bind and activate the pTalpha promoter selectively in immature thymocytes.\",\n      \"evidence\": \"Promoter deletion, EMSA, overexpression, reporter assay in thymocytes\",\n      \"pmids\": [\"11490000\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reliance on reporter/overexpression rather than endogenous locus\", \"Single lab\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Revealed TCF3's separable Wnt-related biochemistry, showing it competes with axin/APC to stabilize beta-catenin and is phosphoregulated by CK1epsilon and GSK3.\",\n      \"evidence\": \"Xenopus extract biochemistry, beta-catenin degradation assays, peptide competition\",\n      \"pmids\": [\"11524435\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship to TCF3's transcriptional repressor role not unified here\", \"Mammalian in vivo relevance untested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Established TCF3 as a beta-catenin-independent repressor maintaining skin stem cell identity, dependent on its DNA-binding and Groucho repressor domains.\",\n      \"evidence\": \"Transgenic domain-deletion overexpression in mouse skin, differentiation markers\",\n      \"pmids\": [\"11445543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct repressed target genes not enumerated\", \"Mechanism of Groucho recruitment in skin not detailed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed E2A directly drives chromatin opening and germline transcription at the Igk locus, with IRF-4 required for recruitment, mechanistically linking E2A to V(D)J accessibility.\",\n      \"evidence\": \"Inducible E47 reconstitution in E2A-null pre-B cells, ChIP, recombination assay, IRF-4 knockdown\",\n      \"pmids\": [\"16428437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin-remodeling cofactors recruited by E2A not identified\", \"Generality to other Ig loci not tested here\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined E2A's checkpoint and survival functions, showing it enforces cell-cycle arrest at the pre-TCR checkpoint and supports B-lymphocyte survival.\",\n      \"evidence\": \"Conditional knockouts, cell-cycle analysis, epistasis, apoptosis assays\",\n      \"pmids\": [\"14685278\", \"15078898\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Survival function not fully mechanistically resolved (idx 16 Medium)\", \"Direct anti-apoptotic targets not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed E2A and HEB act redundantly/jointly to enforce the thymic pre-TCR checkpoint and induce pre-Talpha, formalizing E protein dosage control of T-cell development.\",\n      \"evidence\": \"Double conditional knockout mice, cell-cycle and pre-Talpha analysis, IL-7 stimulation\",\n      \"pmids\": [\"17442955\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Distinct vs shared targets of E2A and HEB not separated\", \"Mechanism of IL-7-driven proliferation increase unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Implicated E2A in antibody diversification by showing it stimulates Ig hypermutation, inferring recruitment of AID to Ig loci.\",\n      \"evidence\": \"E2A inactivation and complementation in DT40 cells, hypermutation frequency assay\",\n      \"pmids\": [\"16785535\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"AID recruitment inferred, not directly demonstrated\", \"Single chicken B-cell model\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed Tcf3 reactivation in committed epidermal cells re-imposes an undifferentiated, Wnt-inhibited stem-cell-like program repressing all skin lineages, establishing it as a master stemness factor in skin.\",\n      \"evidence\": \"Inducible transgenic gain-of-function, expression profiling\",\n      \"pmids\": [\"17018284\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect target separation incomplete\", \"Corepressor dependence not dissected in this study\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified the switch that derepresses TCF3 targets, showing Wnt recruits HIPK2 via beta-catenin to phosphorylate TCF3 and dissociate it from promoters during axis specification.\",\n      \"evidence\": \"Xenopus/mammalian phosphorylation assays, ChIP, phospho-resistant mutants, developmental readouts\",\n      \"pmids\": [\"20951344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphosites and their generality across loci not fully mapped\", \"Conservation in mammalian stem cells not tested here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Reframed Wnt action in ESCs by showing relief of TCF3 repression — not TCF3-beta-catenin activation — is the necessary downstream effect for self-renewal.\",\n      \"evidence\": \"Tcf3 knockout, epistasis with Wnt3a/GSK3 inhibitor, ChIP at Oct4 sites\",\n      \"pmids\": [\"21685894\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repressed target set not enumerated\", \"Quantitative contribution of Tcf1 cooperation unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Tied Tcf3 repression to chromatin state, showing its loss alters genome-wide histone marks and enhances reprogramming of somatic cells.\",\n      \"evidence\": \"Tcf3 knockout ESCs, ChIP for AcH3/H3K9me3, cell-fusion reprogramming assay\",\n      \"pmids\": [\"21730189\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs secondary chromatin effects not separated\", \"Enzymes mediating mark changes not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved the corepressor logic of Tcf3 repression, showing direct cdx4 repression requires Groucho/TLE and HDAC1, and is relieved by corepressor displacement without DNA dissociation.\",\n      \"evidence\": \"ChIP, reporter assays, co-IP, in vivo zebrafish and mammalian cell perturbation\",\n      \"pmids\": [\"21666599\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of corepressor-displacement mechanism beyond cdx4 untested\", \"Single lab/model\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified Foxo1 as a direct E2A target at the earliest stage of B-cell specification, placing E2A atop the specification hierarchy with HEB.\",\n      \"evidence\": \"ChIP at FOXO1 locus, expression in E2A/HEB-deficient CLPs, compound knockouts\",\n      \"pmids\": [\"21972416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of multiple enhancers not weighted\", \"Downstream Foxo1 dependence not formally tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked TCF3 to leukemic surface phenotype by showing genotype-dependent E2A binding controls CD38 transcription in CLL.\",\n      \"evidence\": \"ChIP, siRNA knockdown, flow cytometry in CLL cells\",\n      \"pmids\": [\"21212793\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic basis for allele-specific binding not fully resolved\", \"Single cell-type context\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Distinguished beta-catenin-dependent from -independent TCF3 functions in vivo and defined an indirect Wnt activation route via TCF3 repression of Lef1.\",\n      \"evidence\": \"Tcf3-deltaN knock-in mouse ablating beta-catenin interaction, genetic and expression analysis\",\n      \"pmids\": [\"22573616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Tcf3 targets beyond Lef1 not enumerated\", \"Mechanism of stage-specific requirement unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placed E2A in T-cell commitment by showing it limits Gata3 to enable lineage progression in DN2 thymocytes.\",\n      \"evidence\": \"E2A conditional knockout, Gata3 siRNA rescue, differentiation assays\",\n      \"pmids\": [\"23297135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect repression of Gata3 not established\", \"Other commitment targets not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Generalized E2A's cell-cycle role to cancer by showing it shapes p53 target-gene selectivity (activating p21, repressing PUMA).\",\n      \"evidence\": \"Genome-wide siRNA screen, expression, cell-cycle/apoptosis assays in multiple cancer lines\",\n      \"pmids\": [\"23684607\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect regulation of PUMA not clarified\", \"Mechanism of p53 cooperation unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended TCF3's promoter-occupancy role to hormone signaling, showing constitutive TCF3 occupancy at Lhcgr is required for FSH-induced expression in granulosa cells.\",\n      \"evidence\": \"ChIP, dominant-negative TCF, reporter assay, microarray\",\n      \"pmids\": [\"23754802\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dominant-negative may affect multiple TCFs\", \"Direct TCF3-specific requirement not isolated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed a non-cell-autonomous, beta-catenin-independent role for Tcf3 in wound repair via Stat3-driven induction of secreted lipocalin-2.\",\n      \"evidence\": \"Overexpression, wound healing/conditioned-medium assays, lipocalin-2 neutralization, Stat3 epistasis\",\n      \"pmids\": [\"24909826\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect lipocalin-2 regulation not resolved\", \"In vivo wound contribution single-lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Confirmed at the cellular level that Tcf3-expressing bulge cells are bona fide self-renewing multipotent stem cells across stratified epithelia.\",\n      \"evidence\": \"Tcf3-CreER knock-in lineage tracing\",\n      \"pmids\": [\"25038042\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Descriptive lineage marking, not mechanistic\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated the TCF3-to-TCF4 exchange paradigm at a Wnt target, showing TCF3 represses MYC until beta-catenin activation swaps in TCF4 to drive cell-cycle re-entry.\",\n      \"evidence\": \"ChIP, shRNA of TCF3/TCF4, reporters, GSK3beta inhibition, cell-cycle analysis in colorectal cells\",\n      \"pmids\": [\"25659031\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinetics of factor exchange not resolved\", \"Single cancer-cell context\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established splicing as a regulatory layer, showing hnRNP H/F control the E12/E47 isoform switch with isoform-specific functional outputs (E47 represses E-cadherin) tied to pluripotency.\",\n      \"evidence\": \"hnRNP H/F knockdown, isoform-specific assays, E-cadherin readout in hESCs\",\n      \"pmids\": [\"30115631\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide isoform-specific target differences not mapped\", \"Mechanism of E-cadherin repression specificity unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined distinct lineage-specific cis-elements through which E2A activates Rag genes, with E2A E-box binding essential for chromatin remodeling in T cells.\",\n      \"evidence\": \"Enhancer-deletion and binding-site point-mutant knock-in mice, chromatin conformation, expression\",\n      \"pmids\": [\"32887843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors mediating remodeling at R-TEn not identified\", \"B-cell element mechanism less fully dissected\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended E2A activator function to CD8 memory, showing it remodels enhancers of memory genes to bias memory precursor formation.\",\n      \"evidence\": \"scRNA-seq, GRN analysis, ATAC-seq, E2A ChIP/overexpression\",\n      \"pmids\": [\"33859041\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct target enhancers driving phenotype not pinpointed\", \"Loss-of-function complement not shown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed TCF3 downstream of epigenetic silencing in cancer, defining an EZH2/DNMT3B->TCF3->p21 tumor-suppressive axis in endometrial cancer.\",\n      \"evidence\": \"H3K27me3 ChIP, bisulfite sequencing, TCF3 reporter, inhibitors in CDX/PDX models\",\n      \"pmids\": [\"34175897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect TCF3 silencing contributions not weighted\", \"Single-lab cancer context\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked metabolic and proteostatic control to TCF3, showing SHMT2/mTOR inhibition triggers autophagic TCF3 degradation that collapses tonic BCR signaling essential for Burkitt lymphoma survival.\",\n      \"evidence\": \"CRISPR screen, SHMT2 knockdown, pharmacology, mTOR analysis, TCF3 protein measurement\",\n      \"pmids\": [\"34624079\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Autophagy machinery selectivity for TCF3 not defined\", \"How TCF3 controls tonic BCR mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Uncovered an Id2-LSD1 epigenetic axis acting on Tcf3, where Id2 disrupts a Tcf3-LSD1 complex to preserve H3K4me2 at Tcf3 E-boxes, controlling progenitor exhausted CD8 T cell generation.\",\n      \"evidence\": \"Co-IP, H3K4me2 ChIP, Id2 knockout, LSD1 inhibitor rescue, Id2 HLH mutant\",\n      \"pmids\": [\"38287103\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Tcf3-LSD1 contact interface not mapped\", \"Generality beyond Slamf6 locus untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended TCF3's developmental regulatory role to oogenesis, showing TCF3/TCF12 control enhancer-driven activation of oocyte genes and folliculogenesis.\",\n      \"evidence\": \"H3K27ac ChIP-seq in oocytes, TCF3 knockout, expression analysis\",\n      \"pmids\": [\"38839978\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect target genes not separated\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the activator versus repressor switch of TCF3 is selected at a given locus and cell state — integrating partner choice, isoform, acetylation/degradation, corepressor occupancy, and Wnt signaling into a predictive logic — remains unresolved.\",\n      \"evidence\": \"No single study in the timeline integrates these regulatory layers into a unified mechanistic model\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of TCF3 at native chromatin with cofactors\", \"Quantitative rules governing activator-to-repressor switching are undefined\", \"Crosstalk between degradation, acetylation, and splicing inputs not integrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 7, 8, 11, 33]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 15, 18, 19, 20, 27]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 15, 33]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [6, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 15, 18, 33]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 13, 14, 28, 29, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 10, 11, 12, 35]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1, 14, 22, 29, 35]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [7, 8, 12, 38, 39]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [24, 25, 31]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [3, 4, 5, 6, 34]}\n    ],\n    \"complexes\": [\n      \"E2A-HEB bHLH heterodimer\",\n      \"Tcf3-Groucho/TLE-HDAC1 corepressor complex\",\n      \"SCF(Skp2)-CHIP-Hsc70 E2A pre-ubiquitination complex\"\n    ],\n    \"partners\": [\n      \"HEB\",\n      \"EBF1\",\n      \"LYL1\",\n      \"Skp2\",\n      \"CHIP\",\n      \"p300\",\n      \"HIPK2\",\n      \"beta-catenin\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}